The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© 2020 AFPAvigan maker Fujifilm to seek virus treatment approval after trials
By Kazuhiro NOGI TOKYO©2024 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© 2020 AFP
6 Comments
Login to comment
virusrex
They did (and are still doing in some places) but the Japanese market approval required tests in the country.
drlucifer
Why didn't they do the test abroad in a number of countries to give the results more validity.
virusrex
If you think a company will only try to sell things that are actually effective you don't understand how business are done.
And it is difficult that HCQ result could be superior, It is worse than not treating the patients, the only way it could pretend to work was by systematically select the patients at much higher risk of death to the untreated group so the treated group would survive even with worse treatment just because of that.
Avigan could be faintly effective (reducing a week of hospitalization by 2-4 hours in average for the general population) and it would still be much better than HCQ (and the owners would seek approval for its use, even if for all practical purposes it would give not advantage).
Paul
Also can cause birth defects as it gets into sperm to give some problems in the future. But then nobody ever said life is risk free...
OssanAmerica
Once you're infected and it turns severe enough to end up in the ICU, just about anything with any promise is worth trying.
Raw Beer
This is good news! I am sure there will be some science illiterates who will say the drug is ineffective.
However, hydroxychloroquine results were still superior, in my opinion.